Product Information
ATORVASTATIN 80 MG TABLET is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.0822 per EA under NDC 75834025890. Its NADAC has been published 197 times since Jun 2, 2021.
FDA first approved this application on Aug 19, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Atorvastatin calcium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
80 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834025890
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
ATORVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA213853FDA Approved
8/19/2020
TE Code
AB
On Market Since
8/26/2020
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 80 MG TABLET has been published 197 times since Jun 2, 2021, and over the history we have for it it has declined 21.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0822 per EA |
|---|---|
| All-time high | $0.1165 (Sep 15, 2021) |
| All-time low | $0.0635 (Jul 17, 2024) |
| Median price | $0.0919 |
| Average price | $0.0912 |
| Largest weekly change | -25.7% (Jul 17, 2024) |
| Weeks tracked | 197 |
| Tracking since | Jun 2, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-6.0%
5Y
-29.4%
All
-21.3%
Last surveyed Mar 5, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ATORVASTATIN 80 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 80 MG TABLET, manufactured by Nivagen Pharmaceuticals Inc., is $0.0822 per EA (NDC 75834025890), effective Mar 5, 2025.
How has the price of ATORVASTATIN 80 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 80 MG TABLET has declined 21.3%. It has been tracked across 197 weekly CMS publications since Jun 2, 2021.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 80 MG TABLET?
Since Jun 2, 2021, the NADAC for ATORVASTATIN 80 MG TABLET has ranged from a low of $0.0635 (Jul 17, 2024) to a high of $0.1165 (Sep 15, 2021), with a median of $0.0919 per EA.
Are there cheaper alternatives to ATORVASTATIN 80 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATORVASTATIN 80 MG TABLET, is $0.0692 per EA — about 16% below ATORVASTATIN 80 MG TABLET.
Who manufactures ATORVASTATIN 80 MG TABLET?
ATORVASTATIN 80 MG TABLET (NDC 75834025890) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.